Entheon Biomedical Corp. (ENBI.CN) Research

Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.

Market snapshot

Symbol
ENBI.CN
Price
$0.10
Day change
0.00%
Market cap
$1.4M
P/E ratio
-4.27x
52-week range
0.07-0.45
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Captor Capital Corp. (CPTR.CN)
  • Copland Road Capital Corporation (CRCC.CN)
  • Universal Ibogaine Inc. (IBO.V)
  • Doseology Sciences Inc. (MOOD.CN)
  • Ovation Science Inc. (OVAT.CN)
  • Premier Health of America Inc. (PHA.V)
  • TILT Holdings Inc. (TILT.NE)
  • EGF Theramed Health Corp. (TMED.CN)

Open Entheon Biomedical Corp. (ENBI.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.